Ki Summary BindingDB logo
myBDB logout
Reaction Details
Report a problem with these data
TargetAdenosine deaminase
LigandBDBM577366
Substrate/Competitorn/a
Meas. Tech.Luciferase Reporter Assay
IC50 1.20±n/a nM
Citation Zhang, GZhou, C Pyrazolotriazolopyrimidine derivatives as A2A receptor antagonist US Patent US11472811 Publication Date 10/18/2022
More Info.:Get all data from this article,  Assay Method
 
Adenosine deaminase
Name:Adenosine deaminase
Synonyms:ADA | ADA1 | ADA_HUMAN | Adenosine aminohydrolase
Type:Enzyme
Mol. Mass.:40759.44
Organism:Homo sapiens (Human)
Description:Human recombinant ADA was expressed and purified from an ADA-deficient bacterial strain.
Residue:363
Sequence:
MAQTPAFDKPKVELHVHLDGSIKPETILYYGRRRGIALPANTAEGLLNVIGMDKPLTLPD
FLAKFDYYMPAIAGCREAIKRIAYEFVEMKAKEGVVYVEVRYSPHLLANSKVEPIPWNQA
EGDLTPDEVVALVGQGLQEGERDFGVKARSILCCMRHQPNWSPKVVELCKKYQQQTVVAI
DLAGDETIPGSSLLPGHVQAYQEAVKSGIHRTVHAGEVGSAEVVKEAVDILKTERLGHGY
HTLEDQALYNRLRQENMHFEICPWSSYLTGAWKPDTEHAVIRLKNDQANYSLNTDDPLIF
KSTLDTDYQMTKRDMGFTEEEFKRLNINAAKSSFLPEDEKRELLDLLYKAYGMPPSASAG
QNL
Blast this sequence in BindingDB or PDB
  Blast E-value cutoff:
BDBM577366
n/a
NameBDBM577366
Synonyms:2-(5-amino-2-(furan-2-yl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-7-yl)-N-((cis)-4-hydroxy-4-methylcyclohexyl)-2-(2-methoxyphenyl)propanamide | US11472811, Example 140
TypeSmall organic molecule
Emp. Form.C27H30N8O4
Mol. Mass.530.5783
SMILESCOc1ccccc1C(C)(C(=O)N[C@H]1CC[C@](C)(O)CC1)n1ncc2c1nc(N)n1nc(nc21)-c1ccco1 |wU:16.17,13.13,wD:16.18,(6.67,-1.32,;5.15,-1.08,;4.12,-2.23,;4.59,-3.69,;3.56,-4.84,;2.05,-4.52,;1.58,-3.05,;2.61,-1.91,;2.13,-.44,;1.73,1.05,;3.22,.65,;2.82,2.13,;4.71,.25,;5.8,1.34,;5.4,2.82,;6.49,3.91,;7.98,3.51,;9.46,3.91,;8.38,5,;8.38,2.03,;7.29,.94,;.63,-.12,;0,1.28,;-1.53,1.12,;-1.85,-.38,;-.52,-1.15,;-.52,-2.69,;-1.85,-3.46,;-1.85,-5,;-3.18,-2.69,;-4.65,-3.17,;-5.55,-1.92,;-4.65,-.68,;-3.18,-1.15,;-7.09,-1.92,;-8,-3.17,;-9.46,-2.69,;-9.46,-1.15,;-8,-.68,)|
Structure
Search PDB for entries with ligand similarity:Similarity to this molecule at least: